GlassScriptPhysician profile
Bryan S Palmer
NPI 1730338161
$1,607.43
in general payments reported to CMS, 2019-2025
25 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $143 · 2021: $293 · 2022: $294 · 2023: $251 · 2024: $207 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.31 | 2020-2023 | |
| Exeltis, USA INC. | $190.27 | 2020-2025 | Slynd |
| Organon LLC | $163.73 | 2021-2025 | Nexplanon |
| Evofem Biosciences, INC. | $125.50 | 2021-2023 | Phexxi |
| Bayer Healthcare Pharmaceuticals INC. | $124.21 | 2019-2022 | |
| Coopersurgical, INC. | $90.85 | 2019-2025 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Biogen, INC. | $85.51 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $71.56 | 2021-2025 | Omni Hysteroscope, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $65.61 | 2019-2023 | Veozah |
| Channel Medsystems, INC. | $63.00 | 2024 | |
| Therapeuticsmd, INC. | $59.41 | 2019-2021 | |
| Myovant Sciences INC. | $54.56 | 2021-2022 | |
| Baxter Healthcare | $52.86 | 2025 | Perclot |
| Ethicon US, LLC | $40.09 | 2019-2024 | Dermabond Prineo, Harmonic, Stratafix |
| Merck Sharp & Dohme LLC | $23.67 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $19.20 | 2025 | Prevena |
| Becton, Dickinson and Company | $15.73 | 2024 | Bd Surepath Collection Vial |
| Allergan, INC. | $15.00 | 2019 | |
| Minerva Surgical, INC | $14.34 | 2019 | |
| Shield Therapeutics INC | $13.34 | 2023 | Accrufer |
| Avion Pharmaceuticals | $13.09 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.25 | 2022 | |
| Lupin INC. | $12.12 | 2019 | |
| Dysis Medical, INC. | $11.43 | 2021 | |
| Meditrina | $10.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.